General Annual Meeting (GAM)
This folder contains all the recordings of the GAM.
Special Lecture 1
Chairs: Anke Verlinden & Sophie Servais
Paradigm shifts in managing infections in high-risk hematology patients
Johan Maertens, UZ Leuven, Belgium
Satellite 1 – Astra Zeneca : Recent advances in the treatment of CLL: bringing the patient into the equation
Chair: Vanessa Van Hende
Treatment advances for CLL patients in Belgium during the last decades
Ann Janssens, UZ Leuven, Belgium
Making a shared treatment decision
Jennifer Brown, Dana-Farber Cancer Institute Boston, USA
Elke Stienissen (LVV, BHS patient committee): video testimonial
Q&A
Joint BeSHG-BHS Meeting
Chairs: Helena Devos & Cécile Boulanger
How to detect predisposition: technique, type of tissue, turn around time
Carlijn Brekelmans, UZ Leuven, Belgium
Predisposition in lymphoid malignancies
Esme Waanders, Princes Maxima Center Utrecht, the Netherlands
Advances in Laboratory Technology
Chairs: Ivan Van Riet & Helena Devos
CHIP, CHOP, ARCH: lost in translation
Ann De Becker, UZ Brussel, Belgium
Genetic predisposition in myeloid malignancies
Ine Moors, UZ Gent, Belgium
Highlight 1
Chairs: Timothy Devos & Dominiek Mazure
Management of myelofibrosis: novel approaches and recent evolutions
Jean-Jaques Kiladjian, Hôpital Saint Louis Paris, France
FLT3m+ AML
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
FLT3 Diagnostics: which Test for which Patients?
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
FLT3 Targeted Therapies (1st line and R/R)
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
Liquid Biopsies for Hodgkin and DLBCL (differential) Diagnosis
Laboratory Session at GAM 2021 in collaboration with the Belgian Society of Pathology
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
Which RIC for which AML Patient
Session title: Highlights on Malignant Hematology Part 2
10:30 - 11:00, 30 January, 36th General Annual Meeting
Language: English
MM and Immune Related Therapies
Session title: Highlights on Malignant Hematology Part 1
10:00 - 10:30, 30 January, 36th General Annual Meeting
Language: English